(Press-News.org) Contact information: Catherine Kolf
ckolf@jhmi.edu
443-287-2251
Johns Hopkins Medicine
Potential for added medical benefits uncovered for widely used breast cancer drug
Lab tests show it protects cells from UV radiation, inflammation and oxidative damage
Exemestane, a synthetic steroid drug widely prescribed to fight breast cancers that thrive on estrogens, not only inhibits the production of the hormone, but also appears to protect cells throughout the body against damage induced by UV radiation, inflammation and other assaults, according to results of research by Johns Hopkins scientists.
A summary of the research, performed on a variety of different animal and human cells, was published online in the Proceedings of the National Academy of Sciences on Nov. 4, and suggests that exemestane's effectiveness against breast cancer could be due to more than its ability to halt estrogen production, the scientists say. The study's results further imply that the drug, a so-called aromatase (estrogen synthesis) inhibitor, could potentially be prescribed more widely, including to men, as a way to counteract the wear and tear on cells that often leads to chronic diseases.
"Cells already have their own elaborate protective mechanisms, and in many cases they are 'idling.' The right drugs and foods can turn them on to full capacity," says Paul Talalay, M.D., the John Jacob Abel Distinguished Service Professor of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine. "In our cell studies, we found that exemestane does exactly that," he adds.
Talalay explains that cells are constantly under assault from a wide range of potentially lethal agents. UV radiation from the sun can cause errors in DNA sequences; reactive oxygen species — a class of unstable, oxygen-containing chemicals that are a natural byproduct of cellular functioning — can build up and cause damage to DNA and proteins; and ongoing inflammation can damage many essential cell functions.
To withstand the pressures against them, cells have evolved various mechanisms for protecting themselves. One involves turning on genes that produce a "SWAT team" of proteins, he notes, collectively called the phase 2 response. In normal cells, this response is not fully active. In previous work, the Talalay group found that sulforaphane, a chemical found in broccoli and other vegetables, can ramp up the phase 2 response and help protect cells from the constant wear and tear that they experience.
"Looking at the chemical structure of exemestane, I realized that it was similar to sulforaphane, and I wondered if it too could boost cells' phase 2 protective responses," says Talalay.
To demonstrate that exemestane revs up the phase 2 response, Hua Liu, a research associate in Talalay's laboratory, tested exemestane's effects on various types of cells, including liver tumor and skin cells from a mouse, human cells from the eye's retina, and rat heart cells. As expected, the addition of exemestane elevated the activity of typical protective phase 2 response enzymes in all of the cells tested, a result similar to the effects of adding sulforaphane.
Exemestane was also effective in reducing the amount of reactive oxygen species in human retinal cells, where they are thought to contribute to age-related macular degeneration. It was also able to protect rat heart cells from similar damage.
To test the drug's ability to protect skin cells from UV-induced damage, Liu treated mouse skin cells with exemestane a day before subjecting them to UV radiation and, again, exemestane was able to protect the cells significantly, Liu and Talalay say.
Assessing exemestane's ability to protect cells from inflammation produced a surprise, Talalay notes. In all the other tests, Liu and Talalay had tried not only exemestane but also a mixture of exemestane and sulforaphane. They generally found that the two had an additive effect, suggesting that they both worked in a similar way and were more or less interchangeable. However, when mouse immune cells were exposed to both exemestane and sulforaphane, the two together were much more potent and at lower doses than either chemical alone.
"Our research showed unexpectedly that exemestane has multiple actions, which suggests that a wider use of exemestane should be considered if clinical tests confirm our cellular studies," says Talalay. "Of course, even if clinical tests confirm what we saw in cells, exemestane may not be appropriate for everyone. It's already advocated as a preventive measure for high-risk breast cancer populations, but it may also be valuable in preventing other noncancerous chronic diseases."
Talalay notes that the drug is already approved by the U.S. Food and Drug Administration and taken by tens of thousands of women, with minimal side effects.
###
This work was supported by grants from the Lewis B. and Dorothy Cullman Foundation and from Murakami Noen.
On the Web:
Link to article: http://dx.doi.org/10.1073/pnas.1318247110
Talalay Lab: http://www.hopkinsmedicine.org/pharmacology_molecular_sciences/faculty/bios/talalay.html
Media Contacts: Catherine Kolf; 443-287-2251; ckolf@jhmi.edu
Vanessa McMains; 410-502-9410; vmcmain1@jhmi.edu
Shawna Williams; 410-955-8236; shawna@jhmi.edu END
Potential for added medical benefits uncovered for widely used breast cancer drug
Lab tests show it protects cells from UV radiation, inflammation and oxidative damage
2013-11-07
ELSE PRESS RELEASES FROM THIS DATE:
'Diabetic flies' can speed up disease-fighting research
2013-11-07
'Diabetic flies' can speed up disease-fighting research
Fruit flies make good stand-ins for humans in diabetes treatment tests, UMD study finds
COLLEGE PARK, Md - In a finding that has the potential to significantly speed up diabetes research, scientists at the University ...
Children who have autism far more likely to have tummy troubles
2013-11-07
Children who have autism far more likely to have tummy troubles
The gastrointestinal problems are linked to problem behaviors in children with autism, developmental delay
Children with autism experience gastrointestinal (GI) ...
Speaking a second language may delay different dementias
2013-11-07
Speaking a second language may delay different dementias
MINNEAPOLIS – In the largest study on the topic to date, research shows that speaking a second language may delay the onset of three types of dementias. The research is published in the November 6, 2013, ...
Floods didn't provide nitrogen 'fix' for earliest crops in frigid North
2013-11-07
Floods didn't provide nitrogen 'fix' for earliest crops in frigid North
Floods didn't make floodplains fertile during the dawn of human agriculture in the Earth's far north because the waters were virtually devoid of nitrogen, unlike other areas of the globe scientists ...
Monkeys use minds to move 2 virtual arms
2013-11-07
Monkeys use minds to move 2 virtual arms
DURHAM, N.C. – In a study led by Duke researchers, monkeys have learned to control the movement of both arms on an avatar using just their brain activity.
The findings, published Nov. 6, 2013, in the ...
X-rays reveal inner structure of the Earth's ancient magma ocean
2013-11-07
X-rays reveal inner structure of the Earth's ancient magma ocean
First look into molten basalt at deep mantle conditions
This news release is available in German.
Using the world's most brilliant X-ray source, scientists have for the first ...
Stress makes snails forgetful
2013-11-07
Stress makes snails forgetful
Snail study reveals that stress is bad for memory
New research on pond snails has revealed that high levels of stress can block memory processes. Researchers from the University of Exeter and the University of Calgary trained snails ...
Annual car crash deaths in England and Wales have fallen 40 percent in 50 years
2013-11-07
Annual car crash deaths in England and Wales have fallen 40 percent in 50 years
But may still contribute to social class and gender differences in life expectancy
The annual number of car crash deaths in England and Wales has plunged by 41% over the past ...
Crime associated with higher mortality rates
2013-11-07
Crime associated with higher mortality rates
The new study, published in the journal PLOS ONE shows that people with drug-related criminal records in Norway have a mortality rate that can be up to 15 times higher than people ...
Discovery of HIV 'invisibility cloak' reveals new treatment opportunities
2013-11-07
Discovery of HIV 'invisibility cloak' reveals new treatment opportunities
Scientists have discovered a molecular invisibility cloak that enables HIV, the virus that causes AIDS, to hide inside cells of the body without triggering the body's natural defence systems. ...
LAST 30 PRESS RELEASES:
Can Hayabusa2 touchdown? New study reveals space mission’s target asteroid is tinier and faster than thought
Millisecond windows of time may be key to how we hear, study finds
Graz University of Technology opens up new avenues in lung cancer research with digital cell twin
Exoplanets are not water worlds
Study shows increasing ‘healthy competition’ between menu options nudges patients towards greener, lower-fat hospital food choices
New insights into melanoma plasticity uncover a critical role of iron metabolism
A graphene sandwich — deposited or transferred?
New light-powered motor fits inside a strand of hair
Oil rig study reveals vital role of tiny hoverflies
Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network
iRECODE: A new computational method that brings clarity to single-cell analysis
New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey
QUT scientists create material to turn waste heat into clean power
Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health
Cosmic crime scene: White dwarf found devouring Pluto-like icy world
Major report tackles Covid’s cardiovascular crisis head-on
A third of licensed GPs in England not working in NHS general practice
ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle
Engineers uncover why tiny particles form clusters in turbulent air
GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Psoriasis linked to increased risk of vision-threatening eye disease, study finds
Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity
Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests
Resistance training may improve nerve health, slow aging process, study shows
Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer
SwRI-built instruments to monitor, provide advanced warning of space weather events
Breakthrough advances sodium-based battery design
New targeted radiation therapy shows near-complete response in rare sarcoma patients
Does physical frailty contribute to dementia?
Soccer headers and brain health: Study finds changes within folds of the brain
[Press-News.org] Potential for added medical benefits uncovered for widely used breast cancer drugLab tests show it protects cells from UV radiation, inflammation and oxidative damage